Scientific Advisory Board


Isabelle Leclercq is Professor at the Université Catholique de Louvain. She teaches at the Faculty of Medicine and Dentistry, the Institute of Experimental and Clinical Research and the Pole of Hepato-gastroenterology. Professor Isabelle Leclercq focuses her researches on the understanding of pathogenesis of liver diseases with a specific interest on Non Alcoholic Fatty Liver Disease (NAFLD), Non Alcoholic Steatohepatitis (NASH) or Fibrosis and liver regeneration She has become a key opinion leader in the field of experimental hepatology: she is the co-author of more than 150 scientific publications. She has collaborated with Biocellvia for the development of a fully-automated digital image analysis program dedicated to NASH and NAFLD.

Bernhard Ryffel is a worldwide key opinion leader in the field of respiratory diseases. In 1979, he became scientist in pharmacology for Sandoz/Novartis Pharma. He became professor in pharma-toxicology at Zurich University in 1991, and then professor in immunology at Cape Town University (RSA) in 1995. Since 2001, he has been the director of the immunology department in Orleans (France). Also, since 2004, he has been the visiting professor at several universities all around the world (Asia, Africa…). His research interests are focused on the mechanisms of pulmonary inflammation, progression, repair upon injury and infection. He has authored more than 450 scientific publications, and is a member of editorial boards of well-known publications such as PLoS One, and Molecular Biology. He has collaborated with Biocellvia since 2016.

Stéphanie Solier, PharmD, PhD, has over 16 years of experience in Cancer Research, including 6 years working on a DNA repair project at the National Cancer Institute (NIH, Bethesda, US).
Her PhD studies were dedicated to understanding the role of topoisomerases in alternative splicing, with a focus on caspase-2 gene as a target (INSERM U517, Dijon, France – Dr Corcos). She studied as well the impact of Top1 inhibition by camptothecin on splicing at genome-wide level. In the last years, she joined INSERM U1170 at the Gustave Roussy Cancer Institute (Villejuif, France) to explore interconnections between differentiation and apoptosis, especially in the monocytic lineage. She identified a new target to modulate macrophage polarity in damaged tissues. Since 2017, she is working in close collaboration with Biocellvia, which has a big expertise in pulmonary fibrosis, providing an unique and novel multiparameter image analysis allowing an accurate, reliable and reproducible fibrosis quantification.

Alain DESSEIN, PhD, is a graduate from the Ecole Normale Supérieure. He is a University professor and director of a research laboratory (INSERM). After completing his PhD at the Institut Pasteur, he went to Harvard Medical School to follow a post-doctorate and was appointed two years after deputy professor at Harvard University and research associate at the prestigious Robert B. Brigham Hospital in Boston, Massachusetts (USA). Professor Alain Dessein leads a team specialized in genetics of parasitic diseases at the Medical University (la Timone) in Marseille. He is also a “visiting professor especial” in Brazil where he is advisor in human genetics. Co-founder of GenePred, Alain Dessein also followed a one year program for entrepreneurs at HEC (Challenge +).

Catherine Ronin is Professor at the Université d’Aix-Marseille I. After completing two PhD’s in biochemistry and physics at Université de Provence, she undertook to graduate in Molecular Endocrinology and Laboratory Medicine at USA’s NIH. Professor Catherine Ronin was Guest Professor at the NIH, biotechnology teacher at Polytechnic engineering school. Founder and CEO of Siamed’Xpress society, she trained for company creation and management at IAE.